Yersinia pseudotuberculosis septicemia and HIV

Emerging Infectious Diseases

Volumn 11, Issue 7, 2005, Pages 1128-1130

  Paglia, Maria Grazia ^a   D'Arezzo, Silvia ^a   Festa, Anna ^a   Del Borgo, Cosmo ^a   Loiacono, Laura ^a   Antinori, Andrea ^a   Antonucci, Giorgio ^a   Visca, Paolo ^a,b  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA 16S; LAMIVUDINE; NELFINAVIR; STAVUDINE;

ADULT; ANAMNESIS; ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATE; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSICAL EXAMINATION; RISK FACTOR; SEPTICEMIA; SEROTYPE; YERSINIA PSEUDOTUBERCULOSIS;

EID: 21144442000     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1107.041268     Document Type: Article

References (15)

1. Butler T. Yersinia species, including plague. In: Mandell GL, Douglas RG, Bennett JE. editors. Principles and practice of infectious diseases. 5th ed. New York: Churchill Livingstone; 2000. p. 2406-14.
2. Fukushima H, Matsuda Y, Seki R, Tsubokura M, Takeda N, Shubin FN, et al. Geographical heterogeneity between Far Eastern and Western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high pathogenicity island among Yersinia pseudotuberculosis strains. J Clin Microbiol. 2001;39:3541-7.
3. Chiesa C, Pacifico L, Nanni F, Renzi AM, Ravagnan G. Yersinia pseudotuberculosis in Italy. Attempted recovery from 37,666 samples. Microbiol Immunol. 1993;37:391-4.
4. Ljungberg P, Valtonen M, Harjola VP, Kaukoranta-Tolvanen SS, Vaara M. Report of four cases of Yersinia pseudotuberculosis septicemia and a literature review. Eur J Clin Microbiol Infect Dis. 1995;14:804-10.
5. Deacon AG, Hay A, Duncan J. Septicemia due to Yersinia pseudotuberculosis-a case report. Clin Microbiol Infect. 2003;9:1118-9.
6. Antinori A, Paglia MG, Marconi P, Festa A, Alba L, Boumis E, et al. Short communication: Yersinia pseudotuberculosis septicemia in an HIV-infected patient failed HAART. AIDS Res Hum Retroviruses. 2004;20:709-10.
7. Vos P, Hogers R, Bleeker M, Reijans M, van de Lee T, Homes M, et al. AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res. 1995;23:4407-14.
8. Makino S, Okada Y, Maruyama T, Kaneko S, Sasakawa C. PCR-based random amplified polymorphic DNA fingerprinting of Yersinia pseudotuberculosis and its practical applications. J Clin Microbiol. 1994;32:65-9.
9. Tabacchioni S, Visca P, Chiarini L, Bevivino A, Di Serio C, Fancelli S, et al. Molecular characterization of rhizosphere and clinical isolates of Burkholderia cepacia. Res Microbiol. 1995;146:531-42.
10. Carnoy C, Floquet S, Marceau M, Sebbane F, Haentjens-Herwegh S, Devalckenaere A, et al. The superantigen gene ypm is located in an unstable chromosomal locus of Yersinia pseudotuberculosis. J Bacteriol. 2002;184:4489-99.
11. Cannon CG, Linnemann CC Jr. Yersinia enterocolitica infections in hospitalized patients: the problem of hospital-acquired infections. Infect Control Hosp Epidemiol. 1992;13:139-43.
12. Cornelis GR. Yersinia type III secretion: send in the effectors. J Cell Biol. 2002;158:401-8.
13. Yao T, Mecsas J, Healy JI, Falkow S, Chien Y. Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J Exp Med. 1999;190:1343-50.
14. Monnazzi LG, Carlos IZ, de Medeiros BM. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages. Immunol Lett. 2004;94:91-8.
15. Abe J, Onimaru M, Matsumoto S, Noma S, Baba K, Ito Y, et al. Clinical role for a superantigen in Yersinia pseudotuberculosis infection. J Clin Invest. 1997;99:1823-30.